Emmessar Biotech & Nutrition L
BSE: EMMESSA · Commodity Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 70 companies in Commodity Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹7 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 205.5x in the last 12 months.
- Net loss in 1 of the last 6 quarters.
- Other income was 510% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹22.32 on 2026-10-26: -33.2% from the 52-week high, +21.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -0 | -0 | -0 | -0 | -0 | -0 |
| OPM % | -320.0% | -311.1% | -411.1% | -377.8% | -411.1% | -583.3% |
| Other income | 1 | 1 | 1 | 0 | 0 | 1 |
| Net profit | -0 | 0 | 0 | 0 | 0 | 0 |
| EPS (₹) | 0.16 | 0.34 | 0.23 | 0.23 | 0.01 | 0.26 |
| Revenue YoY | -10.0% | -33.3% | ||||
| Profit YoY | – | -23.5% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 0 | 0 |
| EBITDA | -1 | -1 | -1 | -1 | -1 | -1 |
| Net profit | 0 | 0 | 1 | 0 | 0 | 0 |
| EPS (₹) | 0.94 | 0.99 | 1.48 | 0.61 | 0.81 | 0.73 |
| Revenue growth | +175.7% | -45.1% | +8.9% | -39.3% | – | |
| Profit growth | +4.2% | +50.0% | -57.3% | +37.5% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -28.6% | – | – |
| Net profit | -4.5% | – | – |
| EPS | -6.5% | – | – |
| Share price | – | -30.8% (2y) | -27.8% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 8 | 8 |
| Borrowings | 0 | 0 |
| Cash & equivalents | 7 | 7 |
| Total assets | 9 | 10 |
| Fixed assets | 1 | 1 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Payables | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -0 | -0 |
| Cash from investing | 0 | 0 |
| Cash from financing | 0 | 0 |
| Capex | 0 | 0 |
| Free cash flow | -0 | -0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 4.1% | 5.4% |
| ROCE % | 12.4% | 7.2% |
| Debtor days | 11 | 16 |
| Inventory days | 249 | 404 |
| Payable days | 7 | 504 |
| Cash conversion cycle (days) | 253 | -84 |
| Working capital days | 4,143 | 7,307 |
Peers in Commodity Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SRF | ₹69,362 cr | 30.4x | 4.5x | 16.0% | 15.2% | 21.4% | +373.5% | 0.38% |
| TATACHEM | ₹15,184 cr | – | 0.7x | -10.1% | -4.2% | -1.6% | -4.6% | 1.84% |
| DEEPAKFERT | ₹14,422 cr | 14.7x | 2.1x | 15.1% | 13.6% | 16.7% | +0.6% | 0.89% |
| GNFC | ₹7,634 cr | 7.4x | 0.8x | 11.7% | 15.2% | 14.8% | -8.7% | 3.41% |
| TANFACIND | ₹4,989 cr | 66.3x | 13.4x | 19.7% | 20.5% | 15.5% | +23.8% | – |
| GUJALKALI | ₹4,043 cr | 60.9x | 0.8x | 1.2% | 3.6% | 11.3% | -1.2% | 2.88% |
| GRAUWEIL | ₹3,537 cr | 22.1x | 3.3x | 15.9% | 19.6% | 15.3% | +6.8% | 0.64% |
| GHCL | ₹3,486 cr | 6.7x | 1.0x | 14.9% | 19.9% | 24.8% | -12.3% | 3.29% |
| JGCHEM | ₹2,190 cr | 29.1x | 4.1x | 15.1% | 19.8% | 8.9% | – | 0.18% |
| EMMESSA | ₹11 cr | 30.6x | 1.4x | 5.0% | 6.3% | -423.9% | -28.6% | – |
Business segments (2026-06-30)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Rent on Leasehold Land | ₹0 cr | 69.1% | ₹0 cr | 99.4% |
| Healthcare | ₹0 cr | 9.9% | ₹0 cr | 69.1% |
| Others | ₹0 cr | 21.0% | ₹0 cr | 100.0% |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Commodity Chemicals |
| Sub-industry | Commodity Chemicals |
| Symbol | EMMESSA |
| BSE code | 524768 |
| ISIN | INE634B01016 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.